Why would a 73-year-old patient be prescribed cilazapril?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Why Would a 73-Year-Old Be on Cilazapril?

A 73-year-old patient would most likely be prescribed cilazapril for hypertension (high blood pressure), as ACE inhibitors like cilazapril are first-line antihypertensive agents proven to reduce cardiovascular morbidity and mortality in elderly patients. 1, 2

Primary Indication: Hypertension

Cilazapril is an ACE inhibitor that has demonstrated efficacy and safety specifically in elderly hypertensive patients 3, 4. The evidence strongly supports its use in this age group:

  • ACE inhibitors are recommended as first-line therapy for hypertension in elderly patients, alongside thiazide diuretics, calcium channel blockers, and angiotensin receptor blockers 1, 2
  • Multiple guidelines confirm that age alone should not determine drug selection—the same classes effective in younger patients work equally well in those over 65 years 1
  • Studies specifically in elderly patients (mean age 68 years) showed cilazapril reduced systolic blood pressure by 17 mmHg and diastolic by 11 mmHg 3

Secondary Indication: Heart Failure

Cilazapril may also be prescribed for chronic heart failure, particularly if the patient has systolic dysfunction:

  • ACE inhibitors are effective and well-tolerated in elderly heart failure patients 5
  • The therapeutic approach for systolic dysfunction in elderly patients should be identical to younger patients, though doses should be titrated more cautiously due to altered pharmacokinetics 5
  • Cilazapril showed benefits in heart failure patients, though quality of life improvements were modest 6

Important Considerations for This Age Group

Dosing Adjustments

Initial doses must be lower and titration more gradual in elderly patients 1:

  • Greater likelihood of hypotension and delayed drug excretion
  • Most ACE inhibitors are renally excreted, requiring dose adjustment if creatinine clearance is reduced 5
  • Studies used cilazapril 1-5 mg daily in elderly patients, starting at the lower end 3, 4

Monitoring Requirements

Close supervision is essential when initiating therapy 5:

  • Monitor blood pressure in both supine AND standing positions due to increased orthostatic hypotension risk 1, 7, 1
  • Check renal function and serum potassium levels regularly
  • Watch for hyperkalaemia, especially if combined with potassium-sparing diuretics or NSAIDs 5

Safety Profile in the Elderly

Cilazapril has proven well-tolerated in elderly patients 3, 4, 8:

  • Adverse events occurred in only 9% of elderly patients on cilazapril versus 21% on calcium channel blockers 3
  • No significant effects on mood, sleep, memory, or attention 3
  • Pharmacokinetic studies showed only small age-related changes that don't require routine dose adjustment 9

Common Pitfalls to Avoid

  • Don't withhold ACE inhibitors based on age alone—evidence supports use even in patients over 80 years if well-tolerated 1
  • Don't combine with other RAS blockers (ACE inhibitor + ARB)—this combination is not recommended 2
  • Don't ignore renal function—elderly patients often have reduced creatinine clearance requiring dose modification 5
  • Always check standing blood pressure—orthostatic hypotension is more common in this age group and increases fall risk 1, 7, 1

Likely Treatment Context

Most elderly patients require combination therapy to achieve blood pressure control 1:

  • Preferred combinations include ACE inhibitor + calcium channel blocker or ACE inhibitor + thiazide diuretic 10, 2
  • Target blood pressure remains <140/90 mmHg, same as younger patients, if tolerated 1
  • Single-pill combinations improve adherence and are recommended when using multiple agents 2

References

Research

A pharmacokinetic study of cilazapril in elderly and young volunteers.

British journal of clinical pharmacology, 1989

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.